The U.S. Department of Health and Human Services (HHS) announced a step in the initiative to eliminate hepatitis C (HCV), $100M in pilot funding. The grant is for prevention methods, diagnoses, treatment, and a cure.
The Association for Molecular Pathology (AMP) announced the recipients of its 2025 Excellence in Molecular Diagnostics, Jeffrey A. Kant Leadership and Meritorious Service Awards. These prestigious honors will be presented in November during the AMP 2025 Annual Meeting & Expo in Boston.
The Atellica IM High-Sensitivity Troponin I assay aids in rapid AMI detection and now integrates cTn values as a prognostic indicator to help predict risk of cardiac events and death for up to one year in symptomatic patients. This innovative prognostic claim supports more informed clinical decisions and has the potential to both reduce healthcare burden from repeated emergency visits and help prevent adverse cardiac outcomes.
Clinisys announced the acquisition of Orchard Software from Francisco Partners. The combined capabilities provide for comprehensive, flexible, and scalable informatics offerings that can better serve customers across the global diagnostics market.
Roche announced that new data from its Alzheimer’s development portfolio was presented at the Alzheimer’s Association International Conference (AAIC) in Toronto, Canada (July 27-30).
